LUNGENCLINIC GROSSHANSDORF GMBH
Desconocido
GUIDE.MRD: GUIding multi-moDal thErapies against MRD by liquid biopsies - GUIDE.MRD
LUNGENCLINIC GROSSHANSDORF GMBH
participó en un
HORIZON EUROPE:
HORIZON-JU-IHI-2022-01-single-stage
Advancing personalized approaches in cancer therapy, aiding identification and adaptation of multi-modal treatment strategies for improved o...
2023-05-17 - 2028-04-30 | Financiado
2023-05-17 - 2028-04-30 | Financiado
I3LUNG: Integrative science, Intelligent data platform for Individualized LUNG cancer care with Immunotherap...
LUNGENCLINIC GROSSHANSDORF GMBH
participó en un
HORIZON EUROPE:
HORIZON-HLTH-2021-CARE-05
Immunotherapy (IO) is the new standard of care for many patients with advanced Non-Small Cell Lung Cancer (aNSCLC), yet only around 30-50% o...
2022-05-23 - 2027-05-31 | Financiado
2022-05-23 - 2027-05-31 | Financiado
* No se disponen de datos de la empresa actual.